Sánchez-Sendra, B.; Pérez-Debén, S.; González-Muñoz, J.F.; Murgui, A.; Monteagudo, C.
Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry. Cancers 2022, 14, 2319.
https://doi.org/10.3390/cancers14092319
AMA Style
Sánchez-Sendra B, Pérez-Debén S, González-Muñoz JF, Murgui A, Monteagudo C.
Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry. Cancers. 2022; 14(9):2319.
https://doi.org/10.3390/cancers14092319
Chicago/Turabian Style
Sánchez-Sendra, Beatriz, Silvia Pérez-Debén, José F. González-Muñoz, Amelia Murgui, and Carlos Monteagudo.
2022. "Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry" Cancers 14, no. 9: 2319.
https://doi.org/10.3390/cancers14092319
APA Style
Sánchez-Sendra, B., Pérez-Debén, S., González-Muñoz, J. F., Murgui, A., & Monteagudo, C.
(2022). Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry. Cancers, 14(9), 2319.
https://doi.org/10.3390/cancers14092319